vs
Esperion Therapeutics, Inc.（ESPR）与Porch Group, Inc.（PRCH）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Porch Group, Inc.的1.4倍（$168.4M vs $121.1M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 100.0%），过去两年Porch Group, Inc.的营收复合增速更高（26.4% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Porch Group是一家面向屋主的家居改造服务平台，致力于连接屋主与当地的家居装修承包商。平台不仅提供超过160种家居装修项目的在线预约服务，还涵盖专业建议文章与装修成本指南，帮助屋主便捷规划各类家装工程。
ESPR vs PRCH — 直观对比
营收规模更大
ESPR
是对方的1.4倍
$121.1M
营收增速更快
ESPR
高出43.7%
100.0%
两年增速更快
PRCH
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $121.1M |
| 净利润 | — | $-4.7M |
| 毛利率 | — | 52.7% |
| 营业利润率 | 50.6% | 34.7% |
| 净利率 | — | -3.9% |
| 营收同比 | 143.7% | 100.0% |
| 净利润同比 | — | 2.0% |
| 每股收益（稀释后） | $0.32 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRPRCH
| Q1 26 | — | $121.1M | ||
| Q4 25 | $168.4M | $112.3M | ||
| Q3 25 | $87.3M | $115.1M | ||
| Q2 25 | $82.4M | $107.0M | ||
| Q1 25 | $65.0M | $84.5M | ||
| Q4 24 | $69.1M | $75.3M | ||
| Q3 24 | $51.6M | $77.7M | ||
| Q2 24 | $73.8M | $75.9M |
净利润ESPRPRCH
| Q1 26 | — | $-4.7M | ||
| Q4 25 | — | $-3.5M | ||
| Q3 25 | $-31.3M | $-10.9M | ||
| Q2 25 | $-12.7M | $2.6M | ||
| Q1 25 | $-40.5M | $8.4M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $-29.5M | $14.4M | ||
| Q2 24 | $-61.9M | $-64.3M |
毛利率ESPRPRCH
| Q1 26 | — | 52.7% | ||
| Q4 25 | — | 99.5% | ||
| Q3 25 | — | 75.6% | ||
| Q2 25 | — | 70.9% | ||
| Q1 25 | — | 77.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 79.4% | ||
| Q2 24 | — | 22.1% |
营业利润率ESPRPRCH
| Q1 26 | — | 34.7% | ||
| Q4 25 | 50.6% | 14.7% | ||
| Q3 25 | -11.4% | 14.2% | ||
| Q2 25 | 8.6% | 4.7% | ||
| Q1 25 | -34.0% | -1.5% | ||
| Q4 24 | -6.4% | 33.3% | ||
| Q3 24 | -31.0% | -3.2% | ||
| Q2 24 | 3.5% | -69.2% |
净利率ESPRPRCH
| Q1 26 | — | -3.9% | ||
| Q4 25 | — | -3.1% | ||
| Q3 25 | -35.9% | -9.4% | ||
| Q2 25 | -15.4% | 2.4% | ||
| Q1 25 | -62.2% | 9.9% | ||
| Q4 24 | — | 40.5% | ||
| Q3 24 | -57.2% | 18.5% | ||
| Q2 24 | -83.9% | -84.8% |
每股收益（稀释后）ESPRPRCH
| Q1 26 | — | $-0.04 | ||
| Q4 25 | $0.32 | $0.00 | ||
| Q3 25 | $-0.16 | $-0.10 | ||
| Q2 25 | $-0.06 | $0.00 | ||
| Q1 25 | $-0.21 | $0.07 | ||
| Q4 24 | $-0.14 | $0.34 | ||
| Q3 24 | $-0.15 | $0.12 | ||
| Q2 24 | $-0.33 | $-0.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $68.4M |
| 总债务越低越好 | — | $391.3M |
| 股东权益账面价值 | $-302.0M | $26.3M |
| 总资产 | $465.9M | $806.6M |
| 负债/权益比越低杠杆越低 | — | 14.87× |
8季度趋势，按日历期对齐
现金及短期投资ESPRPRCH
| Q1 26 | — | $68.4M | ||
| Q4 25 | $167.9M | $57.3M | ||
| Q3 25 | $92.4M | $85.0M | ||
| Q2 25 | $86.1M | $79.8M | ||
| Q1 25 | $114.6M | $70.4M | ||
| Q4 24 | $144.8M | $191.7M | ||
| Q3 24 | $144.7M | $238.6M | ||
| Q2 24 | $189.3M | $308.4M |
总债务ESPRPRCH
| Q1 26 | — | $391.3M | ||
| Q4 25 | — | $392.8M | ||
| Q3 25 | — | $387.1M | ||
| Q2 25 | — | $394.1M | ||
| Q1 25 | — | $409.2M | ||
| Q4 24 | — | $403.9M | ||
| Q3 24 | — | $399.0M | ||
| Q2 24 | — | $436.8M |
股东权益ESPRPRCH
| Q1 26 | — | $26.3M | ||
| Q4 25 | $-302.0M | $-24.6M | ||
| Q3 25 | $-451.4M | $-27.9M | ||
| Q2 25 | $-433.5M | $-29.3M | ||
| Q1 25 | $-426.2M | $-52.4M | ||
| Q4 24 | $-388.7M | $-43.2M | ||
| Q3 24 | $-370.2M | $-77.0M | ||
| Q2 24 | $-344.2M | $-101.9M |
总资产ESPRPRCH
| Q1 26 | — | $806.6M | ||
| Q4 25 | $465.9M | $797.4M | ||
| Q3 25 | $364.0M | $787.7M | ||
| Q2 25 | $347.1M | $770.7M | ||
| Q1 25 | $324.0M | $802.3M | ||
| Q4 24 | $343.8M | $814.0M | ||
| Q3 24 | $314.1M | $867.3M | ||
| Q2 24 | $352.3M | $876.1M |
负债/权益比ESPRPRCH
| Q1 26 | — | 14.87× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRPRCH
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $1.2M | ||
| Q3 25 | $-4.3M | $40.8M | ||
| Q2 25 | $-31.4M | $35.6M | ||
| Q1 25 | $-22.6M | $-11.2M | ||
| Q4 24 | $-35.0M | $-26.6M | ||
| Q3 24 | $-35.3M | $12.4M | ||
| Q2 24 | $-7.2M | $-26.0M |
自由现金流ESPRPRCH
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1M | ||
| Q3 25 | — | $40.7M | ||
| Q2 25 | — | $35.4M | ||
| Q1 25 | — | $-11.2M | ||
| Q4 24 | — | $-26.8M | ||
| Q3 24 | $-35.5M | $12.2M | ||
| Q2 24 | $-7.3M | $-26.0M |
自由现金流率ESPRPRCH
| Q1 26 | — | — | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 35.4% | ||
| Q2 25 | — | 33.0% | ||
| Q1 25 | — | -13.3% | ||
| Q4 24 | — | -35.6% | ||
| Q3 24 | -68.7% | 15.7% | ||
| Q2 24 | -9.9% | -34.3% |
资本支出强度ESPRPRCH
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.1% | 0.1% |
现金转化率ESPRPRCH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 13.79× | ||
| Q1 25 | — | -1.33× | ||
| Q4 24 | — | -0.87× | ||
| Q3 24 | — | 0.86× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PRCH
暂无分部数据
